Recent events
Recent events tied to this brand in public sources.
Back to profile9 entries
2026
Alcon acquires Neurotech Pharmaceuticals
Alcon announced that it had acquired Neurotech Pharmaceuticals for $550 million, with possible additional contingent payments tied to commercial milestones.
2022
Alcon completes acquisition of Ivantis
Alcon completed its acquisition of Ivantis, gaining rights to the Hydrus microstent.
2021
Alcon introduces UV-filtering PanOptix and Vivity lenses in Canada
Alcon announced the availability in Canada of four UV-filtering intraocular lenses: AcrySof IQ PanOptix UV, PanOptix Toric UV, Vivity UV and Vivity Toric UV. The lenses were added to Alcon's presbyopia-correcting lens portfolio.
2021
CorNeat Vision and LiveU implement remote surgeon training with Alcon
CorNeat Vision and LiveU announced a partnership and successful implementation of an on-demand Remote Surgeon Virtual Presence solution, working with Alcon's NGENUITY 3D Visualization System to train Canadian cornea experts remotely from Israel.
2021
Pataday Extra Strength becomes available through U.S. retailers
Alcon announced that Pataday Once Daily Relief Extra Strength was available in-store and online at U.S. retailers following its 2020 FDA approval for over-the-counter sale. The product was available in select stores and through online retailers, with wider availability planned to begin that month.
2021
Alcon expands nationwide availability of Clareon IOL with AutonoMe in Canada
Alcon announced the nationwide launch in Canada of the Clareon intraocular lens with the AutonoMe delivery system, expanding availability after an earlier introduction to a select group of Canadian ophthalmologists.
2020
Alcon launches PRECISION1 contact lenses in Canada
Alcon launched PRECISION1 daily disposable silicone hydrogel contact lenses in Canada. Distribution to optometrists had started, with wider availability planned for fall 2020.
2020
FDA approves Pataday products for over-the-counter use
The FDA approved Alcon's Pataday Once Daily Relief and Pataday Twice Daily Relief products for over-the-counter use.
2020
Alcon announces planned U.S. retail availability for Pataday OTC products
Alcon said Pataday Once Daily Relief and Pataday Twice Daily Relief would become commercially available in the United States beginning March 2, 2020, through major drug, food and mass-market retailers. The source reports a plan, not that retail availability had already begun.